The Effect of Citicoline on Electroretinography Abnormalities in Patients with Non-proliferative Diabetic Retinopathy

Introduction : to determine the effect of citicoline 1000 mg oral supplementation given for 4 weeks on electroretinography abnormalities in patients with NPDR (non-proliferative diabetic retinopathy). Methods : prospective, double blind, randomized clinical trial. Thirty-eight patients who matche...

Full description

Bibliographic Details
Main Authors: Anna Nur Utami, Elvioza Elvioza, M Sidik
Format: Article
Language:English
Published: International Journal of Retina 2019-02-01
Series:IJRETINA (International Journal of Retina)
Online Access:https://www.ijretina.com/index.php/ijretina/article/view/53
_version_ 1818875035584036864
author Anna Nur Utami
Elvioza Elvioza
M Sidik
author_facet Anna Nur Utami
Elvioza Elvioza
M Sidik
author_sort Anna Nur Utami
collection DOAJ
description Introduction : to determine the effect of citicoline 1000 mg oral supplementation given for 4 weeks on electroretinography abnormalities in patients with NPDR (non-proliferative diabetic retinopathy). Methods : prospective, double blind, randomized clinical trial. Thirty-eight patients who matched the inclusion and exclusion criteria were randomized into two groups: the placebo (P-NPDR) and citicoline (C-NPDR).  In the end, there were 18 eyes in citicoline group and 16 eyes in placebo group. The primary outcome was P50 and N95 amplitude in PERG within group and intergroup which were taken at the baseline and 4 weeks after treatment. Results : at the end of treatment, the N95 amplitude in C-NPDR showed improvement, 4.85 (1.9-10.3) µV, before treatment to 5.7 (1.9-17.1) µV, after treatment with P = 0.04. Median P50 amplitude improved in both groups, with C-NPDR: 3.1 µV to 3.8 µV (p = 0.89), and P-NPDR: 3.5 µV, to 4.5 µV (p = 0.10). Delta ∆N95 amplitude is higher in C-NPDR, while delta ∆P50 amplitude is higher in P-NPDR, with P values 0.35 and 0.45. Conclusion : Oral citicoline may induce a significant improvement in mean N95 amplitude before and after the treatment. P-NPDR showed positive trend in P50 amplitude while in C-NPDR showed positive trend in N95 amplitude, but these values were not statistically significant (P = 0.45; P= 0.35).
first_indexed 2024-12-19T13:20:06Z
format Article
id doaj.art-7c9edfdffb514e07b8c55209296bbd30
institution Directory Open Access Journal
issn 2614-8684
2614-8536
language English
last_indexed 2024-12-19T13:20:06Z
publishDate 2019-02-01
publisher International Journal of Retina
record_format Article
series IJRETINA (International Journal of Retina)
spelling doaj.art-7c9edfdffb514e07b8c55209296bbd302022-12-21T20:19:44ZengInternational Journal of RetinaIJRETINA (International Journal of Retina)2614-86842614-85362019-02-012153The Effect of Citicoline on Electroretinography Abnormalities in Patients with Non-proliferative Diabetic RetinopathyAnna Nur Utami0Elvioza Elvioza1M SidikJakarta Eye CentreJakarta Eye CentreIntroduction : to determine the effect of citicoline 1000 mg oral supplementation given for 4 weeks on electroretinography abnormalities in patients with NPDR (non-proliferative diabetic retinopathy). Methods : prospective, double blind, randomized clinical trial. Thirty-eight patients who matched the inclusion and exclusion criteria were randomized into two groups: the placebo (P-NPDR) and citicoline (C-NPDR).  In the end, there were 18 eyes in citicoline group and 16 eyes in placebo group. The primary outcome was P50 and N95 amplitude in PERG within group and intergroup which were taken at the baseline and 4 weeks after treatment. Results : at the end of treatment, the N95 amplitude in C-NPDR showed improvement, 4.85 (1.9-10.3) µV, before treatment to 5.7 (1.9-17.1) µV, after treatment with P = 0.04. Median P50 amplitude improved in both groups, with C-NPDR: 3.1 µV to 3.8 µV (p = 0.89), and P-NPDR: 3.5 µV, to 4.5 µV (p = 0.10). Delta ∆N95 amplitude is higher in C-NPDR, while delta ∆P50 amplitude is higher in P-NPDR, with P values 0.35 and 0.45. Conclusion : Oral citicoline may induce a significant improvement in mean N95 amplitude before and after the treatment. P-NPDR showed positive trend in P50 amplitude while in C-NPDR showed positive trend in N95 amplitude, but these values were not statistically significant (P = 0.45; P= 0.35).https://www.ijretina.com/index.php/ijretina/article/view/53
spellingShingle Anna Nur Utami
Elvioza Elvioza
M Sidik
The Effect of Citicoline on Electroretinography Abnormalities in Patients with Non-proliferative Diabetic Retinopathy
IJRETINA (International Journal of Retina)
title The Effect of Citicoline on Electroretinography Abnormalities in Patients with Non-proliferative Diabetic Retinopathy
title_full The Effect of Citicoline on Electroretinography Abnormalities in Patients with Non-proliferative Diabetic Retinopathy
title_fullStr The Effect of Citicoline on Electroretinography Abnormalities in Patients with Non-proliferative Diabetic Retinopathy
title_full_unstemmed The Effect of Citicoline on Electroretinography Abnormalities in Patients with Non-proliferative Diabetic Retinopathy
title_short The Effect of Citicoline on Electroretinography Abnormalities in Patients with Non-proliferative Diabetic Retinopathy
title_sort effect of citicoline on electroretinography abnormalities in patients with non proliferative diabetic retinopathy
url https://www.ijretina.com/index.php/ijretina/article/view/53
work_keys_str_mv AT annanurutami theeffectofciticolineonelectroretinographyabnormalitiesinpatientswithnonproliferativediabeticretinopathy
AT elviozaelvioza theeffectofciticolineonelectroretinographyabnormalitiesinpatientswithnonproliferativediabeticretinopathy
AT msidik theeffectofciticolineonelectroretinographyabnormalitiesinpatientswithnonproliferativediabeticretinopathy
AT annanurutami effectofciticolineonelectroretinographyabnormalitiesinpatientswithnonproliferativediabeticretinopathy
AT elviozaelvioza effectofciticolineonelectroretinographyabnormalitiesinpatientswithnonproliferativediabeticretinopathy
AT msidik effectofciticolineonelectroretinographyabnormalitiesinpatientswithnonproliferativediabeticretinopathy